In vivo selective cancer-tracking gadolinium eradicator as new-generation photodynamic therapy agent

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 51, 2014, Pages E5492-E5497

  Zhang, Tao ^a,b   Lan, Rongfeng ^a   Chan, Chi Fai ^a   Law, Ga Lai ^c   Wong, Wai Kwok ^a   Wong, Ka Leung ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b SOUTH CHINA NORMAL UNIVERSITY   (China)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Gadolinium; Imaging; In vivo PDT; Survivin; Tumor recognition

Indexed keywords

GADOLINIUM; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; RHODAMINE B; SINGLET OXYGEN; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER THERAPY; CELL MEMBRANE; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHOTOCYTOTOXICITY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; ANIMAL; DRUG DELIVERY SYSTEM; NEOPLASMS; PHOTOCHEMOTHERAPY;

ANIMALS; DRUG DELIVERY SYSTEMS; GADOLINIUM; HUMANS; MICE; NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 84919922442     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1414499111     Document Type: Article

References (18)

1. Kamkaew A, et al. (2013) BODIPY dyes in photodynamic therapy. Chem Soc Rev 42(1):77-88.
2. Liang X, Li X, Jing L, Yue X, Dai Z (2014) Theranostic porphyrin dyad nanoparticles for magnetic resonance imaging guided photodynamic therapy. Biomaterials 35(24):6379-6388.
3. Hemmer E, et al. (2013) Upconverting and NIR emitting rare earth based nanostructures for NIR-bioimaging. Nanoscale 5(23):11339-11361.
4. Kachynski AV, et al. (2014) Photodynamic therapy by in situ nonlinear photon conversion. Nat Photonics 8:455-461.
5. Celli JP, et al. (2010) Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization. Chem Rev 110(5):2795-2838.
6. Zhang JX, et al. (2012) A potential water-soluble ytterbium-based porphyrin-cyclen dual bio-probe for Golgi apparatus imaging and photodynamic therapy. Chem Commun (Camb) 48(77):9646-9648.
7. Collins HA, et al. (2008) Blood-vessel closure using photosensitizers engineered for two-photon excitation. Nat Photonics 2:420-424.
8. Bonneau S, Morlière P, Brault D (2004) Dynamics of interactions of photosensitizers with lipoproteins and membrane-models: Correlation with cellular incorporation and subcellular distribution. Biochem Pharmacol 68(7):1443-1452.
9. Zhang JX, et al. (2012) Comparative studies of the cellular uptake, subcellular localization, and cytotoxic and phototoxic antitumor properties of ruthenium(II)-porphyrin conjugates with different linkers. Bioconjug Chem 23(8):1623-1638.
10. D'Souza GGM, Wagle MA, Saxena V, Shah A (2011) Approaches for targeting mitochondria in cancer therapy. Bioenergetics 1807:689-696.
11. Zhang T, et al. (2013) Fast Uptake, water-soluble, mitochondria-specific erbium complex for dual function molecular probe-imaging and photodynamic therapy. RSC Adv 3:382-385.
12. Azenhaa EG, et al. (2002) Heavy-atom effects on metalloporphyrins and polyhalogenated porphyrins. Chem Phys 280:177-190.
13. Schmidt R, Afshari E (1990) Comment on "Effect of solvent on the phosphorescence rate constant of singlet molecular oxygen (1.DELTA.g)." J Phys Chem 94:4377-4378.
14. Khalil GE, et al. (2007) NIR luminescence of gadolinium porphyrin complexes. Chem Phys Lett 435:45-49.
15. Zhang T, et al. (2013) Porphyrin-based ytterbium complexes targeting anionic phospholipid membranes as selective biomarkers for cancer cell imaging. Chem Commun (Camb) 49(65):7252-7254.
16. Hinnen P, et al. (1998) Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: A study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer 78(5):679-682.
17. Idris NM, et al. (2012) In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med 18(10):1580-1585.
18. Ferrario A, Rucker N, Wong S, Luna M, Gomer CJ (2007) Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. Cancer Res 67(10):4989-4995.